Streetbeat News

Products Services

ORCL

Oracle announced plans to develop generative AI services for organizations worldwide in collaboration with Cohere, a leading AI platform for enterprise. The services will be built on Oracle Cloud Infrastructure (OCI) and will span applications to infrastructure, aiming to provide high security, performance, and value.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 1:02 pm

LIVN

LivaNova announced the 150th bipolar depression patient has been randomized in the RECOVER clinical study, assessing the safety and effectiveness of VNS Therapy System. The study aims to offer another treatment option for patients with treatment-resistant depression.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 1:01 pm

NEOG

Neogen Corporation has launched My CatScan 2.0, an upgraded version of its genetic screening test for cats. The new version includes 39 new diseases and genetic traits, offering information on over 120 genetic health conditions. The test uses a noninvasive cheek swab method and provides insights tailored to specific needs.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 12:47 pm

FWBI

MANU

OLB

On June 13th, high-impact movers include MANU with a 30% increase due to a rumored successful bid by Qataris to purchase Manchester United, FWBI with a 134% increase after reaching enrollment target for Phase 2 clinical trial in cystic fibrosis, and OLB with a 112% increase ahead of their presentation at the Emerging Growth Conference on June 14.

Portfolio Pulse from ryanfaloona@benzinga.com

June 13, 2023 | 12:47 pm

NFLX

Netflix (NASDAQ:NFLX) is in early discussions to live-stream its first sporting event, a celebrity golf tournament featuring professional golfers and Formula One drivers. The event would feature celebrities from docuseries 'Drive to Survive' and 'Full Swing'. This marks Netflix's first step into live-streaming sports.

Portfolio Pulse from Akanksha Bakshi

June 13, 2023 | 12:38 pm

DERM

Journey Medical announced positive topline data from the Phase 1 clinical trial of DFD-29, which assessed its impact on microbial flora in healthy adult subjects. This news has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 12:37 pm

DERM

Journey Medical announced that its Phase 1 clinical trial assessing the impact of DFD-29 on the microbial flora of healthy adult subjects achieved all three primary objectives. The subjects completed a 16-week treatment with no significant safety issues.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 12:33 pm

NIO

NIO Inc (NYSE:NIO) shares are trading higher after the company announced plans to cut prices on all of its vehicle models by $4,200 and end free battery swapping for new buyers. Several analysts adjusted price targets on the stock.

Portfolio Pulse from Adam Eckert

June 13, 2023 | 12:32 pm

EEIQ

EpicQuest Education Group International Limited (EEIQ) announced that Davis College signed non-binding MOUs with Urumqi Vocational University (UVU) and Hetu Technology Co, Ltd. The collaborations aim to increase student enrollment, expand international presence, and provide intercultural experiences for Davis College students.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 12:22 pm

PBLA

Panbela has entered into a sponsored research agreement with the University of Texas MD Anderson Cancer Center to evaluate the combination of polyamine metabolic inhibitor therapy and CAR-T cell therapy.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 12:19 pm